Modalis Therapeutics Corporation (4883) Financial Statements

3 Followers

Modalis Therapeutics Corporation Financial Overview

Modalis Therapeutics Corporation's market cap is currently ¥6.44B. The company's EPS TTM is ¥-24.01; its P/E ratio is -3.55; Modalis Therapeutics Corporation is scheduled to report earnings on May 14, 2026, and the estimated EPS forecast is ¥―. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 25	Dec 24	Dec 23	Dec 22	Dec 21
Income Statement
Total Revenue	¥ 0.00	¥ 0.00	¥ 0.00	¥ 40.50M	¥ 1.10M
Gross Profit	¥ 0.00	¥ 0.00	¥ -731.00K	¥ -83.17M	¥ 1.10M
Operating Income	¥ -2.21B	¥ -1.34B	¥ -2.37B	¥ -2.06B	¥ -1.24B
EBITDA	¥ -2.21B	¥ -2.15B	¥ -2.37B	¥ -2.58B	¥ -667.55M
Net Income	¥ -2.15B	¥ -1.32B	¥ -2.39B	¥ -2.70B	¥ -738.96M
Balance Sheet
Cash & Short-Term Investments	¥ 2.81B	¥ 3.58B	¥ 1.88B	¥ 2.93B	¥ 4.94B
Total Assets	¥ 2.96B	¥ 3.69B	¥ 2.03B	¥ 3.13B	¥ 6.07B
Total Debt	¥ 0.00	¥ 0.00	¥ 412.50M	¥ 0.00	¥ 0.00
Net Debt	¥ -2.81B	¥ -3.58B	¥ -1.47B	¥ -2.93B	¥ -4.94B
Total Liabilities	¥ 170.94M	¥ 143.47M	¥ 645.50M	¥ 188.60M	¥ 519.92M
Stockholders' Equity	¥ 2.79B	¥ 3.55B	¥ 1.38B	¥ 2.94B	¥ 5.55B
Cash Flow
Free Cash Flow	¥ -2.12B	¥ -1.43B	¥ -2.29B	¥ -2.09B	¥ -854.58M
Operating Cash Flow	¥ -2.12B	¥ -1.43B	¥ -2.25B	¥ -1.90B	¥ -747.47M
Investing Cash Flow	¥ -2.57M	¥ -188.00K	¥ -39.70M	¥ -185.72M	¥ 171.56M
Financing Cash Flow	¥ 1.35B	¥ 3.04B	¥ 1.22B	¥ 63.68M	¥ 72.63M

Currency in JPY

Modalis Therapeutics Corporation Earnings and Revenue History

Income Statement >

Modalis Therapeutics Corporation Debt to Assets

Balance Sheet >

Modalis Therapeutics Corporation Cash Flow

Cash Flow >

Modalis Therapeutics Corporation Forecast EPS vs Actual EPS

Currently, no data available

Please return soon. This page is being updated.

Earnings >